文献速递区域麻醉与超声疼痛医学

神经周围地塞米松延长臂丛阻滞镇痛的最佳剂量:系统综述与Meta分析

Optimal Dose of Perineural Dexamethasone to Prolong Analgesia After Brachial Plexus Blockade: A Systematic Review and Meta-analysis.
PubMed 文献 · Anesth Analg · 2018-01-01

Meta回归显示神经周围地塞米松4 mg即达封顶效应,与短/中效及长效局麻药联用分别平均延长镇痛约6小时和8小时,且不增加神经并发症风险(证据质量极低)。

要点

  • 神经周围地塞米松4 mg为封顶剂量,超过此剂量镇痛延长效应不再增加。
  • 与短/中效局麻药联用平均延长镇痛约6小时,与长效局麻药联用约8小时。
  • 神经周围地塞米松不增加神经并发症风险(RR 1.40,95%CI 0.54-3.63)。

核心结论

  • 目前极低质量证据表明,神经周围地塞米松4 mg是延长臂丛阻滞镇痛时长的封顶剂量。
  • 与短/中效局麻药联用平均延长镇痛6小时,与长效局麻药联用平均延长8小时。
  • 神经周围地塞米松可能不增加神经并发症风险(极低证据)。

研究设计与样本

  • 系统综述与Meta分析,遵循PRISMA指南,检索MEDLINE、PubMed和EMBASE至2017年1月,无语言限制。
  • 纳入比较神经周围地塞米松联合局麻药与单用局麻药用于臂丛阻滞的对照试验。

主要发现

  • Meta回归显示神经周围地塞米松4 mg在联合短/中效局麻药(8项试验,366例)或长效局麻药(23项试验,1869例)时均呈封顶效应。
  • 亚组分析(低剂量1-4 mg vs 中剂量5-10 mg)证实上述封顶效应。
  • 短/中效局麻药时,低剂量与中剂量组镇痛时长平均差分别为277(234-322)分钟和229(161-297)分钟。
  • 长效局麻药时,低剂量与中剂量组镇痛时长平均差分别为505(342-669)分钟和509(443-575)分钟。
  • 神经周围地塞米松不增加神经并发症发生率(RR 1.40,95%CI 0.54-3.63)。

关键数值与推荐

  • 神经周围地塞米松低剂量定义为1-4 mg,中剂量定义为5-10 mg。
  • 主要结局为各类型局麻药(短/中效和长效)的镇痛时长。
  • 次要结局包括神经并发症发生率、静息疼痛评分及24小时内吗啡消耗量。
  • 主要和次要结局的GRADE证据质量均为极低,主要因局限性、不一致性、间接性和发表偏倚。

临床怎么用

  • 成人上肢手术臂丛阻滞时,可考虑神经周围地塞米松4 mg以延长镇痛,无需使用更高剂量。
  • 与短/中效局麻药联用预期延长镇痛约6小时,与长效局麻药联用约8小时。
  • 现有证据质量极低,临床决策需结合患者具体情况并关注神经并发症风险。

局限性

  • 主要和次要结局的GRADE证据质量均为极低。
  • 证据质量受局限性、不一致性、间接性和发表偏倚影响。
  • 需额外数据探索4 mg以下剂量的效应阈值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Perineural dexamethasone has gained popularity in regional anesthesia to prolong analgesia duration. However, uncertainty remains regarding the optimal perineural dose. Clarification of this characteristic is of significant importance as the administration of dexamethasone may lead to dose-dependent complications. The objective of this meta-analysis was to define the optimal perineural dexamethasone dose to prolong analgesia after brachial plexus blockade for adult patients undergoing upper limb surgery. METHODS: We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement guidelines and searched databases including MEDLINE, PubMed, and EMBASE until January 2017, without language restriction. Only trials comparing perineural dexamethasone and local anesthetics with local anesthetics alone for brachial plexus blocks were included in the present meta-analysis. The Cochrane Collaboration's Risk of Bias Tool was used to assess the methodological quality of each trial and meta-analyses were performed following a random effects model. The primary outcome was duration of analgesia for each type of local anesthetic (short-/intermediate-acting and long-acting local anesthetics). A meta-regression followed by a subgroup analysis were performed to assess the impact of different perineural dexamethasone doses on duration of analgesia; for the latter analysis, trials were grouped in low (1-4 mg) and moderate (5-10 mg) dexamethasone doses. Secondary outcomes included the rate of neurologic complication and resting pain scores and morphine consumption within the first 24 hours. RESULTS: Thirty-three controlled trials, including 2138 patients, were identified. The meta-regression revealed a ceiling effect with a perineural dexamethasone dose of 4 mg when combined with short-/intermediate-acting (8 trials; 366 participants) or long-acting local anesthetics (23 trials; 1869 participants). This finding was confirmed by subgroup analyses comparing low and moderate dexamethasone doses. With short-/intermediate-acting local anesthetics, the mean difference (95% confidence interval) of analgesia duration with low and moderate doses was 277 (234-322) minutes and 229 (161-297) minutes, respectively. With long-acting local anesthetics, the mean differences with low and moderate doses were 505 (342-669) minutes and 509 (443-575) minutes. Perineural dexamethasone did not increase the rate of neurologic complications (risk ratio [95% confidence interval], 1.40 [0.54-3.63]). The Grades of Recommendation, Assessment, Development, and Evaluation quality of evidence for the primary and secondary outcomes were very low, due mainly to limitations, inconsistency, indirectness, and publication bias. CONCLUSIONS: There is currently very low quality evidence that 4 mg of perineural dexamethasone represents a ceiling dose that prolongs analgesia duration by a mean period of 6 and 8 hours when combined with short-/intermediate- or long-acting local anesthetics, respectively. Additional data are needed to explore the threshold for this effect, particularly with doses below 4 mg. The risk of neurologic complications is probably not increased (very low evidence).

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Kirkham KR, Jacot-Guillarmod A, Albrecht E, et al. Optimal Dose of Perineural Dexamethasone to Prolong Analgesia After Brachial Plexus Blockade: A Systematic Review and Meta-analysis. Anesth Analg. 2018. PMID: 28922230. doi:10.1213/ANE.0000000000002488

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。